Chad Stoner
Pfizer (United States)(US)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms, Quinazolinone synthesis and applications, Synthesis and biological activity
Most-Cited Works
- → The road map to oral bioavailability: an industrial perspective(2006)167 cited
- → 2-Substituted Aminopyrido[2,3-d]pyrimidin-7(8H)-ones. Structure−Activity Relationships Against Selected Tyrosine Kinases and in Vitro and in Vivo Anticancer Activity(1998)130 cited
- → Integrated oral bioavailability projection using in vitro screening data as a selection tool in drug discovery(2003)61 cited
- → Discovery of a Series of Imidazo[4,5-b]pyridines with Dual Activity at Angiotensin II Type 1 Receptor and Peroxisome Proliferator-Activated Receptor-γ(2011)52 cited
- → Implementation of an ADME enabling selection and visualization tool for drug discovery(2004)50 cited
- → Integrated in Silico−in Vitro Strategy for Addressing Cytochrome P450 3A4 Time-Dependent Inhibition(2010)50 cited
- → Evaluation of an integrated in vitro–in silico PBPK (physiologically based pharmacokinetic) model to provide estimates of human bioavailability(2005)24 cited
- → The Development and Validation of a Computational Model to Predict Rat Liver Microsomal Clearance(2009)23 cited
- → Moving in Silico Screening into Practice: A Minimalist Approach to Guide Permeability Screening!!(2006)19 cited
- → Synthesis and SAR of tolylamine 5-HT6 antagonists(2009)18 cited